Assignee
CELL GENESYS INC
US·81 granted patents·25 pending applications·6,726 citations·filing 1992–2009
Top patents by PatentIndex Score
106 records- 0198US6428953B1Method and means for producing high titer, safe, recombinant lentivirus vectorsCELL GENESYS INC·Filed 2000·Granted Aug 6, 2002·125 cites·9 claims
- 0298US5994136AMethod and means for producing high titer, safe, recombinant lentivirus vectorsCELL GENESYS INC·Filed 1997·Granted Nov 30, 1999·743 cites·16 claims
- 0398US5413923AHomologous recombination for universal donor cells and chimeric mammalian hostsCELL GENESYS INC·Filed 1992·Granted May 9, 1995·648 cites·12 claims
- 0498US5359046AChimeric chains for receptor-associated signal transduction pathwaysCELL GENESYS INC·Filed 1992·Granted Oct 25, 1994·729 cites·21 claims
- 0597US6319494B1Chimeric chains for receptor-associated signal transduction pathwaysCELL GENESYS INC·Filed 1995·Granted Nov 20, 2001·348 cites·2 claims
- 0697US5686281AChimeric receptor molecules for delivery of co-stimulatory signalsCELL GENESYS INC·Filed 1995·Granted Nov 11, 1997·362 cites·11 claims
- 0796US7179903B2Liver specific transcriptional enhancerCELL GENESYS INC·Filed 2004·Granted Feb 20, 2007·89 cites·9 claims
- 0896US7083981B2Method and means for producing high titer, safe, recombinant lentivirus vectorsCELL GENESYS INC·Filed 2005·Granted Aug 1, 2006·26 cites·14 claims
- 0996US6692736B2Cell-specific adenovirus vectors comprising an internal ribosome entry siteCELL GENESYS INC·Filed 2001·Granted Feb 17, 2004·129 cites·41 claims
- 1096US6436394B1Adenovirus vectors specific for cells expressing androgen receptor and methods of use thereofCELL GENESYS INC·Filed 2000·Granted Aug 20, 2002·90 cites·26 claims
- 1196US6165782AMethod and means for producing high titer, safe, recombinant lentivirus vectorsCELL GENESYS INC·Filed 1999·Granted Dec 26, 2000·182 cites·9 claims
- 1296US5712149AChimeric receptor molecules for delivery of co-stimulatory signalsCELL GENESYS INC·Filed 1995·Granted Jan 27, 1998·176 cites·25 claims
- 1395US6808905B2Lentiviral vectors encoding clotting factors for gene therapyCELL GENESYS INC·Filed 2002·Granted Oct 26, 2004·64 cites·33 claims
- 1495US6103521AMultispecific chimeric receptorsCELL GENESYS INC·Filed 1995·Granted Aug 15, 2000·209 cites·47 claims
- 1595US5686279AMethod for production of high titer virus and high efficiency retroviral mediated transduction of mammalian cellsCELL GENESYS INC·Filed 1994·Granted Nov 11, 1997·151 cites·18 claims
- 1694US7498024B2Compositions and methods for enhanced expression of immunoglobulins from a single vector using a peptide cleavage siteCELL GENESYS INC·Filed 2004·Granted Mar 3, 2009·32 cites·28 claims
- 1793US7473418B2Pan cancer oncolytic vectors and methods of use thereofCELL GENESYS INC·Filed 2005·Granted Jan 6, 2009·31 cites·10 claims
- 1893US7048920B2Recombinant oncolytic adenovirus for human melanomaCELL GENESYS INC·Filed 2002·Granted May 23, 2006·54 cites·19 claims
- 1993US5872005APackaging cell lines for adeno-associated viral vectorsCELL GENESYS INC·Filed 1995·Granted Feb 16, 1999·143 cites·15 claims
- 2093US5858740AMethod for production of high titer virus and high efficiency retroviral mediated transduction of mammalian cellsCELL GENESYS INC·Filed 1995·Granted Jan 12, 1999·91 cites·50 claims
- 2193US5589369ACells homozygous for disrupted target lociCELL GENESYS INC·Filed 1994·Granted Dec 31, 1996·455 cites·11 claims
- 2292US7485291B2Compositions and methods for generating multiple polypeptides from a single vector using a virus derived peptide cleavage site, and uses thereofCELL GENESYS INC·Filed 2003·Granted Feb 3, 2009·33 cites·20 claims
- 2392US6916918B2Human glandular kallikrein enhancer, vectors comprising the enhancer and methods of use thereofCELL GENESYS INC·Filed 2001·Granted Jul 12, 2005·32 cites·14 claims
- 2492US6911200B2Methods of treating neoplasia with combination of target-cell specific adenovirus, chemotherapy and radiationCELL GENESYS INC·Filed 2001·Granted Jun 28, 2005·30 cites·9 claims
- 2592US6585968B2Adenovirus vectors specific for cells expressing alpha-fetoprotein and methods of use thereofCELL GENESYS INC·Filed 2001·Granted Jul 1, 2003·36 cites·22 claims
- 2692US6506604B2Method for production of high titer virus and high efficiency retroviral mediated transduction of mammalian cellsCELL GENESYS INC·Filed 2001·Granted Jan 14, 2003·32 cites·22 claims
- 2792US5834256AMethod for production of high titer virus and high efficiency retroviral mediated transduction of mammalian cellsCELL GENESYS INC·Filed 1993·Granted Nov 10, 1998·104 cites·99 claims
- 2891US7250299B1Method and means for producing high titer, safe, recombinant lentivirus vectorsCELL GENESYS INC·Filed 2000·Granted Jul 31, 2007·31 cites·18 claims
- 2991US6936243B2Adeno-associated viral vector-mediated delivery of DNA to cells of the liverCELL GENESYS INC·Filed 2000·Granted Aug 30, 2005·36 cites·5 claims
- 3091US6514752B1Homologous recombination for universal donor cells and chimeric mammalian hostsCELL GENESYS INC·Filed 1995·Granted Feb 4, 2003·60 cites·14 claims
- 3190US6676935B2Tissue specific adenoviral vectorsCELL GENESYS INC·Filed 1998·Granted Jan 13, 2004·102 cites·31 claims
- 3290US6548286B1Methods for increasing the efficiency of recombinant AAV productCELL GENESYS INC·Filed 1998·Granted Apr 15, 2003·94 cites·14 claims
- 3390US6139835AHomologous recombination for allogeneic donor cellsCELL GENESYS INC·Filed 1995·Granted Oct 31, 2000·54 cites·62 claims
- 3489US7575919B2Adenovirus vectors containing cell status-specific response elements and methods of use thereofCELL GENESYS INC·Filed 2004·Granted Aug 18, 2009·11 cites·9 claims
- 3589US7186699B2Method for treating cancer by vector-mediated delivery of one or more anti-angiogenic or pro-apoptotic genesCELL GENESYS INC·Filed 2004·Granted Mar 6, 2007·52 cites·15 claims
- 3689US6991935B2Target cell-specific adenoviral vectors containing E3 and methods of use thereofCELL GENESYS INC·Filed 2002·Granted Jan 31, 2006·16 cites·19 claims
- 3788US7364727B2Metastatic colon cancer specific promoter and uses thereofCELL GENESYS INC·Filed 2003·Granted Apr 29, 2008·19 cites·12 claims
- 3888US5741899AChimeric receptors comprising janus kinase for regulating cellular pro liferationCELL GENESYS INC·Filed 1995·Granted Apr 21, 1998·80 cites·12 claims
- 3988US5578461AGene manipulation and expression using genomic elementsCELL GENESYS INC·Filed 1993·Granted Nov 26, 1996·121 cites·10 claims
- 4087US7132284B2Adenovirus packaging cell linesCELL GENESYS INC·Filed 2005·Granted Nov 7, 2006·7 cites·23 claims
- 4187US7074618B2Adenoviral E1A/E1B complementing cell lineCELL GENESYS INC·Filed 2004·Granted Jul 11, 2006·14 cites·10 claims
- 4287US7026164B2Adenovirus packaging cell linesCELL GENESYS INC·Filed 2003·Granted Apr 11, 2006·14 cites·11 claims
- 4387US6852528B2Human and mouse uroplakin II gene transcriptional regulatory elementsCELL GENESYS INC·Filed 2001·Granted Feb 8, 2005·26 cites·27 claims
- 4486US7252991B2Method for production of high titer virus and high efficiency retroviral mediated transduction of mammalian cellsCELL GENESYS INC·Filed 2002·Granted Aug 7, 2007·11 cites·1 claims
- 4586US7217421B1Cancer-associated antigens and methods of their identification and useCELL GENESYS INC·Filed 2000·Granted May 15, 2007·25 cites·9 claims
- 4686US6924144B2Method and means for producing high titer, safe, recombinant lentivirus vectorsCELL GENESYS INC·Filed 2002·Granted Aug 2, 2005·8 cites·17 claims
- 4786US6407221B1Chimeric chains for receptor-associated signal transduction pathwaysCELL GENESYS INC·Filed 1995·Granted Jun 18, 2002·65 cites·10 claims
- 4885US7001764B2Compositions comprising tissue specific adenoviral vectorsCELL GENESYS INC·Filed 2002·Granted Feb 21, 2006·14 cites·21 claims
- 4984US7276233B2Methods of treating neoplasia with combinations of target cell-specific adenovirus and chemotherapyCELL GENESYS INC·Filed 2005·Granted Oct 2, 2007·2 cites·4 claims
- 5084US7109029B2Vector constructsCELL GENESYS INC·Filed 2002·Granted Sep 19, 2006·29 cites·27 claims
Showing the top 50 of 106 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →